Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

How Microbes, Mycobacteria, and Metastases May Alter the Way We Look at Rheumatic Diseases

Simon M. Helfgott, MD  |  Issue: October 2012  |  October 1, 2012

The future discoveries in medicine will require a combination of hard work, a fair amount of luck, and large doses of critical, creative thinking. As Kahneman observes, we often have a tendency to become overly reliant on our intuition, which leads us to activate System 1 instead of System 2. Think slow, not fast.

The results of the studies described above have broad implications for our community. Can we manipulate the microbiome to our advantage when treating rheumatic diseases? Can we do so without resorting to using a colonoscope or feeding patients worms? Will vaccine therapies for selected autoimmune diseases ever become a reality? Does the cancer metastases model data translate to RA? In some patients, do RANKL and the SNS play similar roles in translating emotional stress into disease flares?

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The “sex life of the screw worm” was one of many federally funded studies that was attacked as being frivolous by the late U.S. senator from Wisconsin, William Proxmire. From 1975 to 1988, his Golden Fleece Awards highlighted what he considered to be government waste in support of dubious science. But a $250,000 study of this pest, which is lethal to livestock, has, over time, saved the U.S. cattle industry more than $20 billion. Think grateful, that our tax dollars are being used wisely. And keep thinking different.


Dr. Helfgott is physician editor of The Rheumatologist and associate professor of medicine in the division of rheumatology, immunology, and allergy at Harvard Medical School in Boston.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

References

  1. Kahneman D. Thinking, Fast and Slow. New York, N.Y.: Farrar, Straus & Giroux; 2011.
  2. Scher JU, Abramson, SB. The microbiome: A voyage to (our inner) Lilliput. The Rheumatologist. 2011;5(11):1, 32-35.
  3. Me, myself, us. The Economist. August 18, 2012.
  4. Velasquez-Manoff M. An immune disorder at the root of autism. New York Times. August 26, 2012: SR1.
  5. Summers RW, Elliott DE, Urban JF Jr, Thompson R, Weinstock JV. Trichuris suis therapy in Crohn’s disease. Gut. 2005;54:87-90.
  6. Brandt LJ, Aroniadis OC, Mellow M, et al. Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection. Am J Gastroenterol. 2012;107:1079-1087.
  7. Faustman DL, Wang L, Okubo Y, et al. Proof-of-concept, randomized, controlled clinical trial of bacillus-calmette-guerin for treatment of long-term type 1 diabetes. PLoS One. 2012;7:e41756.
  8. Campbell JP, Karolak MR, Ma Y, et al. Stimulation of host bone marrow stromal cells by sympathetic nerves promotes breast cancer bone metastasis in mice. PLoS Biol. 2012;10:e1001363.
  9. Melhem-Bertrandt A, Chavez-Macgregor M, Lei X, et al. Beta-blocker use is associated with improved relapse-free survival in patients with triple-negative breast cancer. J Clin Oncol. 2011;29:2645-2652.

Page: 1 2 3 4 5 6 | Single Page
Share: 

Filed under:Axial SpondyloarthritisConditionsOpinionRheumatoid ArthritisRheuminationsSpeak Out RheumSystemic Lupus Erythematosus Tagged with:Cancergut microbiomeHelfgottLupusmicrobeMicrobiomepatient carevaccine

Related Articles

    Chronic Reactive Arthritis Secondary to Intravesical Bacillus Calmette–Guerin in Bladder Carcinoma

    September 8, 2016

    A 50-year-old man with history of superficial bladder carcinoma presented to our rheumatology clinic for a three-year history of symmetric polyarthralgias. He had undergone multiple transurethral resection of bladder tumor procedures and bacillus Calmette–Guerin (BCG) treatments. Prior to receiving BCG, he was fully functional and employed. Days after receiving his second BCG treatment, he developed…

    How Tuberculosis Has Shaped Medicine and Society

    May 17, 2017

    Pathologists are legendary for blending their work product with the culinary arts. Through the years, their use of delectable foods as descriptors has created a clever way to indelibly link in the minds of clinicians the histopathologic observations of disease with an assortment of these tasty foods: There is the depiction of an apple green…

    The Microbiome in Pediatric Rheumatic Diseases

    The Microbiome in Pediatric Rheumatic Diseases

    April 15, 2016

    The human intestinal microbiota is home to more than 1,000 bacterial species, containing approximately 3 million genes, many of which code for functions that have the potential to affect human physiology.1 Smaller numbers of organisms are also present in the skin, upper gastrointestinal tract, female reproductive tract and the oro- and nasopharynx. As tools have…

    A Duet of Bone and the Immune System

    July 12, 2011

    Examining emerging perspectives in osteoimmunology

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences